Source: International Congress 2016 – ILD pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Karina Portillo Carroz (Barcelona, Spain), Karina Portillo Carroz, Iñaki Salvador-Corres, Eva Martinez -Cáceres, Carmen Centeno-Clemente, Aina Teniente-Serra, Juan Ruiz -Manzano, Alejandro Olivé-Marques. Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study. Eur Respir J 2016; 48: Suppl. 60, 3102

Member's Comments

No comment yet.

Related content which might interest you: The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Utility of bronchoalveolar lavage in vasculitis patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Lung involvement in multiple myeloma - study case Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Eosinophilic lung disease Source: International Congress 2016 – Orphan diseases I Year: 2016 Bronchoalveolar lavage in patients with fibrotic ILDs: is it helpful? Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases Year: 2019